GlassScriptPhysician profile
Mahmood Ali
NPI 1861432320
$8,596.68
in general payments reported to CMS, 2019-2025
22 companies · $528 in 2025
The $528 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,956 · 2020: $1,362 · 2021: $515 · 2022: $420 · 2023: $2,715 · 2024: $1,101 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,692 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,692.22 |
| Travel and Lodging | $651.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,227.85 | 2023 | Acticor 7 Vr-T Dx, Plexa Promri, Edora 8 Dr-T |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,381.89 | 2019-2025 | Lifevest |
| Philips North America LLC | $1,204.88 | 2019-2022 | |
| Abbott Laboratories | $1,043.22 | 2019-2025 | Diamondback Peripheral, Absolute Pro, Confirm Rx |
| Astrazeneca Pharmaceuticals LP | $1,036.86 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $320.72 | 2020-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $279.17 | 2019-2022 | |
| Veryan Medical Incorporated | $150.74 | 2021 | |
| Amgen INC. | $146.82 | 2019-2023 | Repatha |
| Zoll Circulation INC | $133.29 | 2020 | |
| Shockwave Medical, INC | $128.40 | 2020 | |
| Medtronic Vascular, INC. | $127.24 | 2019-2020 | |
| Teleflex LLC | $121.69 | 2025 | Turnpike |
| Cagent Vascular INC | $71.25 | 2024 | Serrantor |
| Cardiovascular Systems INC. | $70.06 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $36.66 | 2022-2024 | S.M.A.R.T. |
| Kestra Medical Technology Services, INC. | $35.39 | 2024 | Assure Wcd |
| Abiomed | $29.39 | 2021 | |
| Gilead Sciences, INC. | $24.96 | 2019 | |
| Cathworks, INC. | $14.71 | 2022 | |
| Tactile Systems Technology INC | $11.49 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmood Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.